1. Clinical aspects of previously treated chromoblastomycosis: A case series from Madagascar
- Author
-
Lala Soavina Ramarozatovo, M.F. Rakotoarisaona, Irina Mamisoa Ranaivo, Muriel Cornet, Mala Rakoto Andrianarivelo, N.H. Razanakoto, M. Andrianarison, Danièle Maubon, Fahafahantsoa Rapelanoro Rabenja, Volatantely Ratovonjanahary, Moril Sata, O. Raharolahy, Fandresena Arilala Sendrasoa, and Tahinamandranto Rasamoelina
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,Antifungal ,medicine.medical_specialty ,Antifungal Agents ,medicine.drug_class ,Itraconazole ,030106 microbiology ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Cicatricial lesion ,medicine ,Madagascar ,Humans ,lcsh:RC109-216 ,Prospective Studies ,030212 general & internal medicine ,Prospective cohort study ,Terbinafine ,Aged ,Chromoblastomycosis ,business.industry ,General Medicine ,Middle Aged ,University hospital ,medicine.disease ,Dermatology ,Infectious Diseases ,Female ,Previously treated ,business ,Fluconazole ,medicine.drug - Abstract
Objective To describe the clinical aspects of chromoblastomycosis (CBM) presented by patients who had received incomplete antifungal treatment before consultation. Methods A prospective study of patients with clinically suspected CBM was performed between 2013 and 2018 in the Department of Dermatology at the University Hospital Antananarivo, and during consultation campaigns. Results Patients develop CBM over a period of more than 10 years, and many will have already received antifungals prescribed by general practitioners before consulting with a dermatologist. Such treatment obviously modifies the clinical presentation. From the 63 CBM patients in this large study, we describe 12 patients who received oral antifungals (terbinafine, griseofulvine, itraconazole, fluconazole) before consultation. The most frequent clinical aspect presented by these patients was cicatricial lesions, which are characteristically smooth and non-elevated, and enlarge by peripheral extension, with atrophic scarring at the center. Conclusion Our study is the first to show that cicatricial lesions are a clinical aspect presented by CBM patients who received antifungals before presentation.
- Published
- 2020